Funds holding WEREWOLF THERAPEUTICS INC
ISIN US95075A1079 · United States
- Fund holders
- 9
- Of which ETFs
- 0 9 other funds
- Value held
- ≈ 1.4M $ 1.2M $ · 118.6K €
- Share of capital
- 3.2 % of 48.6M shares on Jul 27, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 873,745 | 727.5K $ | 1.80 % | as of Mar 31, 2026 ↗ | |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 344,231 | 286.6K $ | 0.00 % | 0.71 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 167,131 | 100.3K $ | 0.00 % | 0.34 % | as of Feb 28, 2026 ↗ |
| Ultra-Small Company Market Fund Bridgeway Funds, Inc. | 75,000 | 62.4K $ | 0.05 % | 0.15 % | as of Mar 31, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 54,577 | 32.8K $ | 0.11 % | as of Feb 28, 2026 ↗ | |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 42,628 | 25.6K $ | 0.09 % | as of Feb 28, 2026 ↗ | |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 12,833 | 7.7K $ | 0.03 % | as of Feb 28, 2026 ↗ | |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 500 | 416.3 $ | 0.00 % | as of Mar 31, 2026 ↗ | |
| VIFAG 2002, SICAV S.A. GESALCALA, S.A., S.G.I.I.C. | 118.6K € | 0.14 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| VIFAG 2002, SICAV S.A. GESALCALA, S.A., S.G.I.I.C. | 0.14 % | as of Dec 31, 2025 ↗ |
| Ultra-Small Company Market Fund Bridgeway Funds, Inc. | 0.05 % | as of Mar 31, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 0.00 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 8 | 0 | 1,570,645 | +4.4 % |
| 2026Q1 | 8 | 0 | 1,503,788 | -6.0 % |
| 2025Q4 | 8 | -28 | 1,599,751 | -23.5 % |
| 2025Q3 | 36 | -41 | 2,091,447 | -42.4 % |
| 2025Q2 | 77 | -2 | 3,632,391 | -1.6 % |
| 2025Q1 | 79 | -8 | 3,690,385 | -0.4 % |
| 2024Q4 | 87 | +36 | 3,703,946 | +67.3 % |
| 2024Q3 | 51 | +20 | 2,213,972 | +52.1 % |
| 2024Q2 | 31 | +7 | 1,455,683 | +21.0 % |
| 2024Q1 | 24 | +3 | 1,203,396 | +32.9 % |
| 2023Q4 | 21 | 905,817 |
Institutional managers
45 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 6,681,307 | 5.6M $ | as of Mar 31, 2026 |
| MPM BIOIMPACT LLC | 1,208,810 | 1M $ | as of Mar 31, 2026 |
| Lynx1 Capital Management LP | 657,786 | 547.7K $ | as of Mar 31, 2026 |
| SPHERA FUNDS MANAGEMENT LTD. | 626,810 | 521.9K $ | as of Mar 31, 2026 |
| DC Funds, LP | 589,102 | 490.5K $ | as of Mar 31, 2026 |
| Squadron Capital Management LLC | 563,535 | 469.2K $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 516,218 | 429.8K $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 389,487 | 324.4K $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 264,583 | 220.1K $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 132,050 | 109.9K $ | as of Mar 31, 2026 |
| STATE STREET CORP | 119,168 | 99.2K $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 101,608 | 84.6K $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 86,851 | 72.3K $ | as of Mar 31, 2026 |
| Alyeska Investment Group, L.P. | 86,554 | 72.1K $ | as of Mar 31, 2026 |
| JANE STREET GROUP, LLC | 82,836 | 69K $ | as of Mar 31, 2026 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 77,000 | 64.1K $ | as of Mar 31, 2026 |
| UBS Group AG | 66,857 | 55.7K $ | as of Mar 31, 2026 |
| XTX Topco Ltd | 50,929 | 42.4K $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 38,266 | 31.9K $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 33,799 | 28.1K $ | as of Mar 31, 2026 |
| SIMPLEX TRADING, LLC | 32,526 | 27.1K $ | as of Mar 31, 2026 |
| Verdad Advisers, LP | 29,760 | 24.8K $ | as of Mar 31, 2026 |
| RAYMOND JAMES FINANCIAL INC | 19,778 | 16.5K $ | as of Mar 31, 2026 |
| HRT FINANCIAL LP | 17,861 | 14 $ | as of Mar 31, 2026 |
| CERTUITY, LLC | 15,000 | 12.5K $ | as of Mar 31, 2026 |
Declared shareholders of WEREWOLF THERAPEUTICS INC
There are 2 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| RA Capital Management, L.P. and 3 others | 6.00 % | 2,915,742 | as of Jun 24, 2026 · SCHEDULE 13D |
| MPM BioVentures 2014, L.P. and 13 others | 3.80 % | 1,826,646 | as of May 8, 2026 · SCHEDULE 13D |
Cite this page
Titelia. "Funds holding WEREWOLF THERAPEUTICS INC". https://titelia.com/en/stocks/werewolf-therapeutics-inc-US95075A1079